A Meta-Analysis Evaluating the Incidence of Bleeding Events With Intravenous Defibrotide Treatment Outside the Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome Setting
Sign Up to like & getrecommendations! Published in 2020 at "Clinical and Applied Thrombosis/Hemostasis"
DOI: 10.1177/1076029620935202
Abstract: Defibrotide is approved to treat hepatic veno-occlusive disease/sinusoidal obstruction syndrome (VOD/SOS) with renal/pulmonary dysfunction following hematopoietic cell transplantation (HCT) in adult and pediatric patients in the United States, and to treat severe hepatic VOD/SOS post-HCT… read more here.
Keywords: defibrotide; vod sos; intravenous defibrotide; bleeding events ... See more keywords
Incidence of Bleeding in Patients with Sickle Cell Disease: A Population Based Study
Sign Up to like & getrecommendations! Published in 2018 at "Blood"
DOI: 10.1182/blood-2018-99-114223
Abstract: Background: Bleeding in patients with sickle cell disease (SCD) occurs at a number of sites, often with significant morbidity and mortality. The increased risk of hemorrhagic stroke, hematuria, and vitreous hemorrhage in SCD patients is… read more here.
Keywords: incidence; risk; disease; incidence bleeding ... See more keywords